Corcept Therapeutics, Inc.
(NASDAQ : CORT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.03%61.940.0%$779.50m
VRXValeant Pharmaceuticals International, Inc. -2.07%28.8614.1%$169.82m
CTLTCatalent, Inc. 0.28%141.412.0%$168.28m
PRGOPerrigo Co. Plc 0.55%43.016.9%$140.02m
ICLRICON plc 0.56%283.042.8%$122.12m
HZNPHorizon Therapeutics Plc 0.80%110.375.5%$106.97m
JAZZJazz Pharmaceuticals Plc 0.63%135.352.1%$104.94m
INDPIndaptus Therapeutics, Inc. -6.86%8.820.0%$101.49m
ARGXargenx SE -3.15%308.000.0%$64.03m
BHCBausch Health Cos., Inc. -2.07%28.860.0%$60.89m
ENDPEndo International Plc -3.85%3.258.5%$56.03m
UTHRUnited Therapeutics Corp. -2.68%195.1014.0%$46.59m
AXSMAxsome Therapeutics, Inc. 1.34%33.401.8%$38.98m
IRWDIronwood Pharmaceuticals, Inc. 3.54%13.459.5%$24.56m
SAGESAGE Therapeutics, Inc. -1.69%45.427.6%$21.56m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.